Cancer Clinical Trial
Official title:
Finding a Simple Message to Improve Dietary Quality for Cancer and Heart Disease
We hypothesize that adding beneficial high fiber foods to the diet will result in better overall dietary quality (measured by the Alternate Healthy Eating Index), which has been shown to be associated with cancer, than either reducing saturated fat, or a combination of high fiber and low saturated fat.
Summary of Grant:
Several studies have demonstrated that poor dietary quality is associated with obesity and
certain cancers, such as gastrointestinal, colorectal, and hormonal cancers. Dietary
interventions aimed at improving diet are plagued by poor adherence, possibly due to the
complexity of changing multiple diet components. Complex public health messages are
associated with worse adherence and reduced capacity to impact health outcomes. If a simple
public health recommendation for diet was effective at changing multiple aspects of diet,
adherence and impact could be maximized. However, research has yet to test which single
dietary message has the greatest impact on overall diet quality, and consequently, potential
for cancer and heart disease prevention. Thus far, dietary interventions have tested varying
combinations of multiple recommendations; however, a single dietary recommendation may have
a synergistic beneficial effect on other areas of diet, precluding the need to make the
message overly complex.
The present study compares 3 dietary change conditions that are hypothesized to have high
potential for synergistic effects on other unaddressed areas of diet, and consequently
overall dietary quality. Patients were randomized to one of three arms:
1. low saturated fat diet (≤7% of total calories);
2. high fiber diet (≥30 grams of total fiber per day);
3. combination arm: low saturated fat and high fiber.
Each participant was instructed to reduce calories by -500 kcal/day from his/her resting
metabolic rate (RMR), but total calories was not less than 1200 calories per day.
Additionally, Dr. Ira Ockene, professor of medicine, director of preventive cardiology
program, generously offered to pay for blood draws and blood lipids and glucose analysis at
each visit to make the study valuable from both cancer and heart disease research
perspectives.
Specific aims:
1. Develop intervention materials. Intervention materials that specifically aid
participants towards a low saturated fat or high fiber diet, or combination change
developed for each condition.
2. Preliminary test of intervention. We will calculate change in diet quality, lipids,
body weight, waist circumference, and blood pressure at 3- and 6-months. We hypothesize
that the single change conditions will produce more changes than the complex condition
and that adding beneficial high fiber foods to the diet will result in improved dietary
quality (measured by the Alternative Healthy Eating Index) than reducing saturated fat.
Secondary outcomes include calorie intake, micro- and macronutrients at baseline,
physical activity, and observe changes at 3- and 6-months.
3. Adherence. We will examine adherence to the treatment protocol so that appropriate
adjustments to the intervention can be made, if necessary, to enhance adherence in the
larger randomized clinical trial.
4. Data for sample size estimation. We will document means and standard deviations on
measures so that sample size can be estimated for the larger randomized clinical trial.
;
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05346796 -
Survivorship Plan HEalth REcord (SPHERE) Implementation Trial
|
N/A | |
Recruiting |
NCT05094804 -
A Study of OR2805, a Monoclonal Antibody Targeting CD163, Alone and in Combination With Anticancer Agents
|
Phase 1/Phase 2 | |
Completed |
NCT04867850 -
Effect of Behavioral Nudges on Serious Illness Conversation Documentation
|
N/A | |
Enrolling by invitation |
NCT04086251 -
Remote Electronic Patient Monitoring in Oncology Patients
|
N/A | |
Completed |
NCT01285037 -
A Study of LY2801653 in Advanced Cancer
|
Phase 1 | |
Completed |
NCT00680992 -
Study of Denosumab in Subjects With Giant Cell Tumor of Bone
|
Phase 2 | |
Completed |
NCT00062842 -
Study of Irinotecan on a Weekly Schedule in Children
|
Phase 1 | |
Active, not recruiting |
NCT04548063 -
Consent Forms in Cancer Research: Examining the Effect of Length on Readability
|
N/A | |
Completed |
NCT04337203 -
Shared Healthcare Actions and Reflections Electronic Systems in Survivorship
|
N/A | |
Recruiting |
NCT04349293 -
Ex-vivo Evaluation of the Reactivity of the Immune Infiltrate of Cancers to Treatments With Monoclonal Antibodies Targeting the Immunomodulatory Pathways
|
N/A | |
Terminated |
NCT02866851 -
Feasibility Study of Monitoring by Web-application on Cytopenia Related to Chemotherapy
|
N/A | |
Active, not recruiting |
NCT05304988 -
Development and Validation of the EFT for Adolescents With Cancer
|
||
Completed |
NCT04448041 -
CRANE Feasibility Study: Nutritional Intervention for Patients Undergoing Cancer Surgery in Low- and Middle-Income Countries
|
||
Completed |
NCT00340522 -
Childhood Cancer and Plexiform Neurofibroma Tissue Microarray for Molecular Target Screening and Clinical Drug Development
|
||
Recruiting |
NCT04843891 -
Evaluation of PET Probe [64]Cu-Macrin in Cardiovascular Disease, Cancer and Sarcoidosis.
|
Phase 1 | |
Active, not recruiting |
NCT03844048 -
An Extension Study of Venetoclax for Subjects Who Have Completed a Prior Venetoclax Clinical Trial
|
Phase 3 | |
Completed |
NCT03109041 -
Initial Feasibility Study to Treat Resectable Pancreatic Cancer With a Planar LDR Source
|
Phase 1 | |
Completed |
NCT03167372 -
Pilot Comparison of N-of-1 Trials of Light Therapy
|
N/A | |
Terminated |
NCT01441115 -
ECI301 and Radiation for Advanced or Metastatic Cancer
|
Phase 1 | |
Recruiting |
NCT06206785 -
Resting Energy Expenditure in Palliative Cancer Patients
|